>
Organization
Bristol-Myers Squibb Company
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Bristol-Myers Squibb Company

... coming up with generic versions of the drugs. Key Players Boehringer Ingelheim Bristol-Myers Squibb DAIICHI SANKYO Johnson & Johnson Sanofi Topics Covered PART 03: MARKET ...
... as AXIM Biotechnologies, Boston Pharmaceutical, Castle Creek Pharma, Dermavant Sciences, JN Biosciences, Bristol-Myers Squibb, Incyte Corporation, Clinuvel Pharmaceuticals etc. and their Vitiligo drugs development are ...
... Saha, M.D., Ph.D., senior vice president and global head of translational medicine, Bristol-Myers Squibb. 'The information we glean from this collaboration will ultimately inform the ...
... BiosanaPharma BV BioStem Technologies Inc Biotec Pharmacon ASA BreStem Therapeutics Inc Bristol-Myers Squibb Co C4X Discovery Holdings PLC Celdara Medical LLC Celgene Corp Certa Therapeutics ...
... with this particularly high-risk leukemia," said Fouad Namouni, M.D., head, oncology development, Bristol-Myers Squibb. The application is based on data from CA180-372 (NCT01460160), an ongoing ...
... benefits of immunotherapy. Under the terms of the multi-year agreement, H3 and Bristol-Myers Squibb will jointly conduct the research focused on developing immune therapies using ...
... Amid an industrywide shift away from the sector, Bristol-Myers Squibb is close to becoming the latest Big Pharma to exit consumer ...
... Bristol-Myers Squibb is tapping Eisai spinoff H3 Biomedicine and its RNA-splicing technology for ...
... .1365 from .13 AT&T Inc .51 from .50 Amgen 1.45 from 1.32 Bristol-Myers .41 from .40 CenterPoint Energy .2875 from .2775 CH Robinson Wrldwd .50 ...
... Pipeline Products Product DescriptionResearch and DevelopmentProduct Development ActivitiesReason for dormancy/discontinuation Companies Mentioned Bristol-Myers SquibbHSRx BiopharmaceuticalOsel IncAnGes MG For more information about this drug pipelines report ...
Subscribe now for full coverage on Bristol-Myers Squibb Company
Start My Free Trial